ImmunoGen, Inc. was a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and was headquartered in Waltham, Massachusetts. From Wikipedia
Shareholders of ICVX, EAR, CVLY, IMGN could see significant changes in the wake of proposed sales.
